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Abstract: Background: Cardiovascular and chronic kidney diseases are a part of non-
communicable chronic diseases, the leading causes of premature death worldwide. They are recog-
nized as having early origins through altered developmental programming, due to adverse envi-
ronmental conditions during development. Preterm birth is such an adverse factor. Rates of preterm 
birth increased in the last decades, however, with the improvement in perinatal and neonatal care, a 
growing number of preterm born subjects has now entered adulthood. Clinical and experimental 
evidence suggests that preterm birth is associated with impaired or arrested structural or functional 
development of key organs/systems making preterm infants vulnerable to cardiovascular and 
chronic renal diseases at adulthood. This review analyzes the evidence of such cardiovascular and 
renal changes, the role of perinatal and neonatal factors such as antenatal steroids and potential 
pathogenic mechanisms, including developmental programming and epigenetic alterations. 
Conclusion: Preterm born subjects are exposed to a significantly increased risk for altered cardio-
vascular and renal functions at young adulthood. Adequate, specific follow-up measures remain to 
be determined. While antenatal steroids have considerably improved preterm birth outcomes, re-
peated therapy should be considered with caution, as antenatal steroids induce long-term cardio-
vascular and metabolic alterations in animals’ models and their involvement in the accelerated cel-
lular senescence observed in human studies cannot be excluded.  
Keywords: Preterm infant, small for gestational age, preeclampsia, antenatal glucocorticoids, nephron number, hypertension, 
cardiovascular disease, chronic kidney disease, DOHaD, programming, noncommunicable diseases, adult. 
1. INTRODUCTION 
 The incidence rates of Preterm Birth (PTB) vary from 5 
% to 14 % worldwide and have increased over the last dec-
ades; about 13 million infants are born preterm each year [1, 
2]. Preterm birth is the leading cause of neonatal mortality 
especially in low and middle-income countries [1, 2]. How-
ever, with improved perinatal and neonatal care over the last 
three decades, a growing cohort of early preterm-born infants 
has survived  the neonatal period and has entered adulthood. 
 Although a number of preterm born infants, including 
extremely premature birth newborns, survive with no or mild 
neuro-developmental impairment and enjoy a satisfying 
quality of life, evidence from clinical and experimental stud-
ies suggests that PTB is associated with developmental 
changes that may expose them to long-term chronic, Non-
Communicable Diseases (NCDs). The incidence of NCDs is 
increasing especially in low and middle-income countries 
and is the leading cause of death worldwide [3, 4]. Cardio-
vascular Diseases (CVDs) are known to be the first 
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cause of premature mortality in high-income countries; how-
ever, the health impact of Chronic Renal Disease (CRD) is 
underestimated. CRD is a silent and insidious disease that 
affects about 10% of the population. Cardiovascular and 
renal systems overlap; CRD, in turn, increases the occur-
rence of cardiovascular events and death [5].  
 While preterm subjects are exposed, on the long-term, to 
altered regulation of a number of biologic organ/systems, 
this review focuses on the link between preterm birth and the 
risk of long-term cardiovascular and renal diseases, on the 
role of perinatal and neonatal conditions and on the underly-
ing pathophysiological mechanisms. Possible preventive 
guidance from infancy to adulthood addressed to health care 
providers, families and preterm individuals will be consid-
ered as well. 
2. PRETERM BIRTH AND LONG-TERM CARDIO-
VASCULAR AND RENAL ISSUES: CLINICAL EVI-
DENCE 
2.1. Cardiovascular Consequences 
 The link between PTB and elevated Blood Pressure (BP) 
is clearly established [6-8]. The POP Study included 422 
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young adults (mean age 19-year-old) born preterm with Ges-
tational Age (GA) less than 32 weeks (or birth weight < 
1500 g) in the Netherlands. The proportions of participants 
in the pre-hypertensive stage or with   hypertension (HTN) 
were 45% and 10 % respectively [9, 10]. A recent, large 
meta-analysis study   found that systolic (SBP) and diastolic 
(DBP) blood pressure levels were on average 3.4 mmHg 
(95% confidence interval, 2.2-4.6) and 2.1 mmHg (1.3-3.0) 
higher, respectively, in preterm young adults than those of 
their peers born at term [8].  These differences were higher 
in preterm born women and remained significant after ad-
justments for age, gender, maternal smoking or family his-
tory of arterial HTN. Morover, these differences were found 
across variuos situations  that led to preterm birth, with a sig-
nificantly higher impact of maternal preeclampsia. Such dif-
ferences may translate into a higher risk of gestational hyper-
tension or preeclampsia, as shown in the Canadian cohort 
study [11]. A slight increase in arterial blood pressure at 
young adulthood has an important impact on health later on. 
[12, 13]. For instance, a 5 - 10 mmHg increase in DBP is 
associated with a 34 % increased risk of stroke [14, 15]. 
Such a modest difference in BP might also contribute to a 2 
fold increased risk of cerebrovascular disease, as reported in 
adult blood preterm individuals in a large Swedish  popula-
tion based study [16]. These findings suggest that infants 
who are born preterm have modestly elevated BP at young 
adulthood, but are susceptible to develop HTN with associ-
ated other cardiovascular and renal complications.  
 A growing evidence shows that PTB is associated with 
changes in heart structure and function [17-20]. Left Ven-
tricular Mass (LVM) has been shown to be 2 fold higher 
during the first months of life in preterm infants compared to 
those born at term (+ 56% vs. + 34 %, respectively) [16, 17]. 
Lewandowsky et al. also found a similar pattern of increased 
LVM (mean difference of + 10 g/m
2
) with an abnormal 
geometric shape and reduced systolic and diastolic ventricu-
lar functions in young adults born preterm [19]. The LVM 
was inversely related to GA and independent on BP. Data on 
heart structure and function in preterm born subjects are still 
scarce and conflicting [20]. However, structural changes are 
of concern since ventricular hypertrophy is a known risk 
factor for heart failure and mortality for coronary diseases 
[21, 22]. A Swedish population-based study has shown such 
a possible association [23]. Compared with individuals born 
at term, the risk of heart failure was 17 and 4 fold higher 
after extremely (<28 weeks) and very (28 to 31 weeks) PTB 
respectively.  
2.2. Renal Consequences 
 Several studies have demonstrated a link between low 
birth weight and Chronic Kidney Disease (CKD) [24-26]. In 
a recent meta-analysis which included 18 studies (n = 
46,249), low birth weight was associated with CKD with 
overall Odds Ratio (OR) of 1.73 (95% confidence interval 
[CI], 1.44 to 2.08), proteinuria (OR, 1.81; 95% CI, 1.19 to 
2.77) and end-stage renal disease (OR, 1.58; 95% CI, 1.33 to 
1.88) [24]. Unfortunately, GA was not accurately investi-
gated in almost all studies, although PTB may be considered 
to account for approximately 80 % of low birth weight. In 
young adults born preterm, Glomerular Filtration Rate 
(GFR) seems preserved within normal ranges although it has 
been found positively correlated to body weight, not to GA, 
as reported in the POP Study [10, 27]. In this study, GFR 
increased by 1.2 to 3.0 ml/min per 1.73 m2 per 1 BW-SDS 
increase [10]. Only one study has shown a reduced kidney 
size and volume in young adults born preterm with an ap-
propriate birth weight for GA (AGA) [28]. Available data 
regarding long-term consequences of preterm birth on renal 
functions and structure are rare and support the preserved 
GFR and reduced kidney size (which is a surrogate marker 
of nephron mass) in young adulthood. But it is not excluded 
that renal functions could rapidly decline over time in this 
vulnerable population. The association between low birth 
weight and CKD has been demonstrated in several studies 
[29, 30-32]. In a case-control study, Lackland et al. [29] 
found in African Americans and Caucasians participants 
from the southeastern United States, a U-shaped association 
between birth weight and CKD, with the highest odds ratio 
of renal failure in the lowest birth weight group. Nelson et 
al. [30] found in 308 Pima Indians aged 20 to 61 years, a 
strong association between low birth weight (< 2500g) and 
abnormal urinary albumin excretion measured by albu-
min/creatinine ratio (ACR  30 mg/g). Moreover, data from 
a cohort of 526 subjects in Norway showed that an increased 
risk of End-Stage Renal Disease (ESRD) is associated to low 
birth weight  (< 10
th





   percentiles [31]. The National Kidney 
Foundation’s Kidney Early Evaluation Program (KEEP) 
[32], revealed in 12364 participants (2902 men and 9444 
women), a gender-dependent association between birth 
weight and CKD. In this study, the adjusted odds ratio of 
CKD was 1.65 for men with a birth weight < 2500g as com-
pared to men with a birth weight between 3000g and 3999g. 
However, there was no association among women. On the 
other hand, Lackland et al. [29] found in their cohort of 2676 
men and 1014 women, that low birth weight is significantly 
associated with higher risk of ESRD compared with normal 
birth weight for women, but not for men. The gender differ-
ences in the association between low birth weight and CKD 
can be explained by the measuring outcomes. In the KEEP 
study, outcome measures include early stages of CKD and 
the study of Lackland et al. measured end-stage renal dis-
ease. 
3. INFLUENCE OF PERINATAL AND NEONATAL 
CONDITIONS 
 Perinatal and neonatal conditions may shape the link be-
tween PTB and long-term chronic diseases. Preterm birth is 
associated with various perinatal conditions, such as 
preeclampsia or maternal hypertensive disorders, gestational 
diabetes, chorioamnionitis, preterm premature rupture of 
membranes, and Intra-Uterine Growth Restriction (IUGR). 
After birth, infants have to face up, untimely and with imma-
ture organ functions, an extra-uterine, stressing environment 
that involves a different physiology for nearly all known 
biologic systems, and includes oxidative stress and exposure 
to drugs, sub-optimal nutrition, life support and intensive 
care techniques.  
 Preeclampsia is independently associated with vascular 
alterations and elevated BP levels [8, 33, 34]. Growing evi-
dence from experimental studies has linked antenatal gluco-
corticoids and long-term metabolic, cardiovascular and renal 
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diseases [35]. Antenatal glucocorticoids are widely used in 
perinatal care as part of a short course of glucocorticoids 
prescribed for women at risk of preterm birth which reduce 
the risk of neonatal morbidity and mortality [36]. Benefits 
may be further increased after repeated doses, but with ad-
verse consequences on fetal growth. A growing trend to-
wards  reduced GFR and increased markers of insulin resis-
tance has been reported in young adults born preterm and 
exposed prenatally to a short course of glucocorticoids [37, 
38]. Although reassuring, long-term follow-up is required 
since experimental findings highlight long-term occurrence 
of cardiovascular and renal diseases after a short course of 
antenatal glucocorticoids [36, 39]. 
 Preterm infants born very/extremely preterm or Small for 
Gestational Age (SGA) are at particular risk of cardiovascu-
lar and renal diseases [10, 13, 40]. In a Swedish population-
based study of more than 300 000 twenty-year-old men, Jo-
hansson S et al. have shown that the risk of hypertension was 
inversely correlated to GA and was 2 fold higher in ex-
tremely preterm individuals (GA < 28 weeks) [41]. Super-
imposed SGA seems to increase the risk of cardiovascular 
and renal diseases. In a Young Finns Study, the cardiovascu-
lar risks were elevated showing mean SBP levels that are 7 
mmHg higher in SGA preterm group than in the AGA pre-
term group [13]. The prevalence of proteinuria was about 2-
fold higher in SGA (3.8 %) than in AGA (1.6 %) individuals 
in the POP Study [10].  
 Nutrition and growth during infancy and childhood are 
key determinants of adult health. Accelerated catch-up 
growth, especially following early postnatal growth restric-
tion may bear deleterious long-term consequences on cardio-
vascular, metabolic and renal functions and structure [42-
46]. We and other groups have previously reported that al-
though adults who were born preterm in the 80’s - 90’s have 
represented an accelerated growth pattern, a large proportion 
of them suffers from Extra-Uterine Growth Restriction 
(EUGR) [45, 47, 48]. The “sensitive period of development” 
during which growth and nutrition have critical effects on 
long-term cardiovascular and renal health is still unknown. 
Growth as early as during the neonatal period can influence 
cardio-metabolic parameters [45, 49, 50]. In young adult-
born preterm, Kerkhof et al. have shown that  neonatal 
asymmetric overgrowth (weight  gain + 0.5 SD) and rapid 
weight gain up to 3 months after hospital discharge were 
associated with metabolic disturbances, with high fat deposi-
tion and abnormal insulin sensitivity [48, 49]. Nutritional 
practice in neonatal intensive care units has evolved during 
the last decade with a shift toward increased protein and en-
ergy intake from birth onwards to prevent EUGR. High pro-
tein content post-discharge formulas are often used to 
achieve catch-up growth. The long-term renal and cardiovas-
cular consequences of such nutritional approach are un-
known. Recent experimental findings highlight short and 
long-term adverse renal effects of neonatal high protein diet 
especially in low birth weight offspring [51, 52]. In a ran-
domized clinical trial, the team of Lucas A has shown lower 
blood pressure and better insulin sensitivity in breastfed pre-
term born adolescent [53, 54]. Lewandowsky et al. also 
found improved myocardial function and heart structure in 
breastfed young preterm adults [55]. Protein intake during 
the neonatal period can impact adult health later on. In the 
Finns preterm cohort, Matinolli HM et al. have shown that 
young preterm adult neonatally exposed to protein defi-
ciency, at a time when protein and calories intake were usu-
ally limited in NICUs, have reduced muscle mass [56]. This 
phenotype may decrease sensitivity to insulin. It can be 
speculated that EUGR and caloric-protein deficiency affect the 
development of various system and expose preterm born in-
fants to early catch-up growth with adverse long-term cardio-
vascular and metabolic functions. However, further investiga-
tions are needed to determine the long-term consequences of 
neonatal and infant nutrition and to accurately define the 
growth profile at risk of cardiovascular and renal diseases. 
While fetal growth restriction has been shown to exert long-
term effects on cardio-vascular and metabolic health, postnatal 
nutrition is more likely to act a second hit after the effects of 
antenatal conditions and the stress of being born preterm. 
4. DEVELOPMENTAL DISTURBANCES  
 Preterm birth occurs during key phases of fetal growth 
and development. Rapid fetal growth is supported in part by 
arterial growth and the capillary network development. The 
myocardium develops in low blood pressure system and the 
kidney in a “stress-free environment”, as depuration func-
tions are ensured by the placenta. The intra-uterine environ-
ment provides various vascular trophic/growth factors, hor-
mones, progenitors and stem cells essential for the optimal 
growth and development of the fetus. A premature exposure 
to the extra-uterine environment may accelerate the matura-
tion process at the expense of proliferative mechanisms, alter 
developmental programming of long-term biologic functions 
and injure key organs, with lifelong consequences including 
an increased vulnerability to cardiovascular and renal dis-
eases at adulthood. 
4.1. Preterm Birth and the Cardiovascular System 
 Changes in micro and macro-vascular structure and func-
tions have been observed in children and young adult born 
preterm [27, 57-63]. These changes which predominaly af-
fect preterm infants born SGA or after maternal preeclamp-
sia, include reduction in aortic size, peripheral capillary rare-
faction (decreased retinal and cutaneous capillary density), 
altered intima-media thickness, increased arterial stiffness, 
and impaired arterial endothelium-dependent vasodilation 
[27, 34, 57-64]. Altered vascular structure or function seems 
established early in the neonatal period, even before any pos-
sible influence of postnatal nutrition. We have reported im-
paired arterial stiffness in preterm infants at term corrected 
age, which seems sustained at adulthood [47, 64, 65]. The 
underlying mechanism is incompletely understood but may 
involve inadequate elastin synthesis and altered endothelial 
function [57, 66]. Appropriate angiogenesis is necessary for 
the development of all organs and systems, and if altered, 
may pave the way to increased vascular resistance and sys-
temic HTN later on. We recently reported impaired angio-
genic activities of circulating Endothelial Colony-Forming 
Cells (ECFCs) from cord blood of preterm infants [67]. 
These Progenitor Endothelial Cells (PECs) affect angiogene-
sis, fetal growth/development, and vascular repair mecha-
nisms [68]. As compared with term infants, these EPCs from 
preterm infants were decreased in number, showed impaired 
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proliferation and migration activities and were unable to 
form robust capillary networks in vitro and in vivo [67]. The-
ses dysfunctions were related to both premature senescence 
process (through decreased expression of SIRT1) and an 
anti-angiogenic environment involving the VEGF/ 
sVEGF/PF4 pathway [69, 70]. The influence of particular 
perinatal conditions is little known. An additional factor con-
sisted of the biogenesis of pro-senescent microparticles by 
endothelial colony forming cells, driven by SIRT1-
dependent epigenetic regulation of MKK6 [71]. However, 
such changes are reversible as PECs of preterm infants ex-
posed in vitro to resveratrol, show restored angiogenic prop-
erties [69]. In addition, many of the infants enrolled in these 
studies received antenatal steroids which may contribute to 
accelerated maturation and development arrest. 
 Preterm birth is associated with changes in myocardial 
functions and structure. In humans, 80% of cardiomyocytes 
number is reached at term. After birth, the proliferation proc-
esses gradually cease and move on to postnatal maturation 
with cardiomyocyte enlargement [72]. When PTB occurs, 
the heart development occurs in an unanticipated environ-
ment and needs to face up transitional hemodynamic changes 
from low to high resistance hemodynamic system. In moder-
ately preterm lambs, Bensley et al. have demonstrated that 
the heart exhibited hypertrophic and abnormal cardiomyo-
cyte maturation with increased rate of triploid cells, a marker 
of cardiomyocyte dysfunction and interstitial fibrosis [73]. 
Cardiomyocytes number was unchanged in these animals 
born moderately preterm. Other perinatal conditions sur-
rounding frequently PTB can alter the heart development 
[74]. In particular, fetal growth restriction and neonatal ex-
posure to hyperoxia in immature animals have been reported 
to induce cardiomyocyte deficit, ventricular hypertrophy and 
long-term susceptibility to heart failure [75, 76].  
 All subtle cardiovascular changes observed in healthy 
young adult constitute risk factors of CVDs. Capillary mi-
crovascular rarefaction is a major determinant of HTN 
through increased vascular resistance [77]. Increased arterial 
stiffness, intima-media thickness and impaired endothelium-
dependent vasodilation relate to arteriosclerosis and other 
cardiovascular events [78, 79]. These vascular changes and 
the further development of HTN worsen ventricular hyper-
trophy which in turn increases the risk of cardiovascular 
death [22].  
4.2. Preterm Birth and Kidney Development 
 Low birth weight is associated with nephron deficit in 
humans and animals but the impact of PTB on nephron en-
dowment is still debated [44]. In humans, nephrogenesis 
ends achieves prenatally at around 34–36 weeks and 60 % of 
the nephrons are formed during the third trimester of preg-
nancy, mostly between 28 and 34 weeks of gestation. In the 
case of an extremely preterm infant, nephrogenesis ends ap-
proximately 40 days after birth [80]. Thus, the final endow-
ment of nephrons is both dependent on gestational age at 
birth and intrauterine environment [81]. The average neph-
ron number per kidney is ±750,000, with a wide interindi-
vidual range (250,000–1,900,000) [82]. Birth weight is the 
principal marker of nephron endowment, but various factors 
including IUGR, maternal diet restriction, micronutrient de-
ficiency, iron deficiency, maternal gestational diabetes, 
chorioamnionitis, maternal gestational administration of glu-
cocorticoids or exposure to other drugs/toxics, can induce 
nephron deficit [44]. According to Brenner’s hypothesis, 
nephron deficit increases Single Nephron Glomerular Filtra-
tion Rate (SNGFR) to meet excretory demands [16]. Blood 
pressure is also elevated to ensure sufficient natriuresis, 
named “pressure natriuresis”. These adaptive hemodynamic 
changes are responsible for glomerular hypertension, glome-
rular and tubular enlargement, renal hypertrophy and renal 
injury. Low Birth Weight (LBW) results in a reduced num-
ber of nephrons with secondary glomerular hypertension and 
development of non-nephrotic Focal Segmental Glomerulo-
sclerosis (FSGS) [81]. However, a recent study conducted by 
Conti et al. found in a cohort of 89 children with idiopathic 
nephrotic syndrome, that LBW constitutes a risk factor of 
FSGS and cortico-dependence, and children with nephrotic 
syndrome and LBW needed heavier immunosuppressive 
treatment compared to children with normal birth weight 
[83]. Conti et al. suggest a conditioning role for hemody-
namic and podocyte changes due to reduced nephron en-
dowment in children with LBW [83]. Moreover, various 
postnatal factors including nutrition and protein intake can 
subsequently amplify this adaptive mechanism. In low birth 
weight rat offspring, we and others have found out that neo-
natal overfeeding or high protein intake induced hyperten-
sion, proteinuria, accelerated renal insufficiency and glome-
rular sclerosis [51, 52, 84, 85]. Nephron deficit appears as a 
vulnerable condition when other postnatal “hits” accelerate 
the development of CRD and HTN. A rationale exists for 
avoiding EUGR, and subsequently the need for catch-up 
growth [47], targeting as much as possible linear growth 
over the fetal and postnatal periods based on individualized 
growth charts and precision or individualized fine-tuning of 
nutrition, although such approach needs to be confirmed by 
randomized controlled trials. 
 While intrauterine growth restriction is associated with 
nephron deficit by an average of 30-35%, the effects of PTB 
on nephron endowment are still debated. Nephron formation 
may continue after birth but with premature cessation of 
nephrogenesis [86]. Studies of autopsies indicate an acceler-
ated maturation and enlarged glomeruli [86, 87]. These 
structural changes have been observed in preterm animals as 
well [88, 89]. It must be kept in mind that the babies in-
cluded in these studies were likely to be the sickest among 
the patients and to have suffered from prolonged postnatal 
stress (IUGR, dys-nutrition, inflammation/infection, oxida-
tive stress) which might have compromised the progress of 
nephrogenesis. In particular, Bacchetta et al. have shown 
reduced kidney volume (surrogate marker of nephron mass) 
and GFR in 7-year-old children born preterm and AGA and 
subsequently exposed to early EUGR [90].  Acute renal in-
sufficiency is associated with reduced renal volume 
(approximate marker of nephron mass) in preterm children 
[91]. Experimental studies in immature animals also found 
detrimental effects of neonatal undernutrition and oxidative 
stress on nephron endowment [84, 92, 93]. In contrast, neo-
natal overfeeding enhances nephron endowment suggesting 
that environmental factor can promote postnatal nephrogene-
sis [85]. The renal effects of antenatal glucocorticoids are 
unknown in humans while experimental studies have dem-
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onstrated significant nephron deficit in offsprings [39]. The 
severity of immaturity may also play a critical role. When 
comparing the experimental findings one can speculate that 
the earlier the PTB occurs during nephrogenesis, the greater 
is the nephron deficit [88, 89]. An autopsy study of 122 
adults showed a significant association between birth weight 
and nephron number [94]. Altogether, these data suggest that 
nephron formation is compromised at least in the most im-
mature infants, in SGA preterm infants and in sickest infants 
who have severe neonatal complications and EUGR. More 
studies are clearly needed to assess factors influencing the 
postnatal renal development in preterm infants.  
4.3. Epigenetic Mechanisms 
 The mechanisms by which PTB or perinatal and neonatal 
conditions affect the development of various organ making 
preterm infants vulnerable cardiovascular and renal diseases 
are unknown, but may involve altered developmental pro-
gramming and epigenetic mechanisms.  
 There is increasing evidence that early epigenetic im-
printing, which memorizes early interactions between genes 
and the environment, and translates them into durable 
changes in gene expression, is strongly influenced by PTB 
[95]. This is not as surprising as the fact that epigenetics are 
key mechanisms in normal cell differentiation, therefore in 
organ and function development, by silencing part of the 
genome which is not involved in the differentiated cell func-
tions, and enhancing the expression of the genes specifically 
involved in such functions. Arrested development and al-
tered developmental programming are likely factors, within 
the general frame of the Developmental Origins of Health 
and Disease concept (DOHaD). Accordingly, during the sen-
sitive and vulnerable period of early development, stimuli 
related particularly to stress, nutrition and toxicants do not 
only have short term effects, but may also influence lifelong 
health and may rely on epigenetic changes of genes regula-
tion as a molecular support. Emerging findings show that all 
three principal mechanisms of epigenetic alterations, DNA 
methylation, histones modifications and non coding RNAs 
have been associated with changes in the expression of spe-
cific genes involved during development, and in PTB.  
 Pham et al. have found a reduced methylation rate of the 
P53 gene, involved in apoptosis in IUGR rats kidneys with 
nephron number deficit [96]. Studies from our group have 
identified several epigenetic modifications underlying the 
altered angiogenic capacity of preterm infants endothelial 
progenitor cells, which shows that the multiple epigenetic 
mechanisms are at work. The deficit in SIRT1 expression 
associated with accelerated senescence in these cells is re-
lated to a modification in the methylation of the Lys in posi-
tion 9 in histone 3 [69], while the pro-senescence character-
istics of endothelial microparticles released by senescent 
ECFCs from preterm infants are associated with a change in 
histone 3 Lys 9 deacetylation [71]. Conversely, we recently 
observed that the methylation of the AMOT gene, which 
codes for amotilin, a pro-angiogenic factor, is inversely cor-
related with GA in 5 CpG islands of the promoter. The ob-
servation that the lower the GA, the higher the methylation 
rate of the pro-angiogenic gene AMOT contrasts with the 
otherwise established trend toward increasing genes methy-
lation with GA in preterm infants, and suggests an additional 
explanation to the decreased angiogenic capacity of preterm 
infants ECFCs [97].  
 However, the role of antenatal exposure to exogenous 
steroids, given to accelerate fetal maturation, needs further 
investigations to be ruled out as a confounding factor. Ani-
mal models experiments suggest indeed that antenatal expo-
sure to synthetic steroids before birth leads to an increased 
BP and altered genes methylation [39, 98]. 
CONCLUSION AND PERSPECTIVES 
 Evidences that young adults born preterm display infra-
clinical structural and functional changes in key organs, 
making them at high risk of developing cardiovascular and 
renal diseases later on. These changes are observable early 
after preterm birth across the population of preterm born 
subjects. A variety of stressing events occurring during the 
perinatal and infancy periods are likely to shape the risk for 
chronic diseases in such population. Sub-optimal nutrition, 
typically EUGR associated with excess catch-up growth may 
act as a second hit. More research, focused on the underlying 
mechanisms, on identifying early biomarkers of risk and 
potential therapeutic targets, including epigenetic ones, is 
needed to better define individual risk profiles and facilitate 
early prevention [98, 99]. 
 Available data are now sufficient to recommend a spe-
cific and extended follow-up in preterm born subjects.  
 Preventive strategies during the most susceptible period 
of development (up to term corrected age and during the first 
two years of life) may mitigate the long-term adverse conse-
quences of PTB. Such strategies may be set at individual and 
societal levels. Their main components involve efforts to 
improve global maternal gestational health and nutrition, 
prevent preterm birth and SGA, avoid repeated courses of 
antenatal steroids, promote maternal milk as first-line nutri-
tion, avoid EUGR and promote linear growth without over-
growth after hospital discharge, avoid exposure to passive 
smoking, limit exposure to nephrotoxic drugs from neonatal 
to adulthood, and to promote a healthy lifestyle including 
regular physical activity.  
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